Target intelligence / Profile preview

MRGPRF antisense RNA 1 (MRGPRF-AS1)

Target: MRGPRF-AS1
Molecular classification: Long non-coding RNA (lncRNA), Other (not enzyme, receptor, transporter, transcription factor, ion channel, histone modification, etc.)

Overview

MRGPRF antisense RNA 1 (MRGPRF-AS1) is a long non-coding RNA gene located on chromosome 11 (position 69,012,283–69,018,447, GRCh38). It does not encode a protein and is classified as lncRNA[1][3]. There are no reported direct functional roles, disease associations, or drug interactions for MRGPRF-AS1. The protein-coding gene in the same locus, MRGPRF, is a MAS-related G protein-coupled receptor family member with established tumor suppressor roles in cutaneous melanoma and involvement in cell cycle and PI3K/Akt signaling[1][2][3][5]. However, MRGPRF-AS1 itself should not be confused with MRGPRF, and current available data do not support its status as a classic therapeutic molecule or receptor. MRGPRF-AS1 is a long non-coding RNA, not a classic therapeutic target, receptor, or protein. The query presupposes target receptor biology that does not apply to this gene, risking confusion with the protein-coding MRGPRF gene. There is no substantive evidence of MRGPRF-AS1 involvement in therapeutic targeting or disease biology beyond standard lncRNA gene function annotation[1][3].

Other names: MRGPRF-AS1MRGPRF Antisense RNA 1Lnc-MRGPRF-6:1

Biological functions

Regulatory RNA (possible gene expression regulation)Other (no specific biological functions have been established for MRGPRF-AS1 in the literature)

Disease associations

Other (no explicit or validated disease association reported for MRGPRF-AS1. The related MRGPRF coding gene has documented roles in cancer, especially cutaneous melanoma, but this does not specifically apply to the antisense RNA[2][5].)

Beyond the preview

Go deeper on MRGPRF antisense RNA 1 (MRGPRF-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MRGPRF antisense RNA 1 (MRGPRF-AS1).

Explore the full profile